Department of Veterinary Pharmacology, Graduate School of Agriculture and Life Sciences, The University of Tokyo, Tokyo, Japan.
Am J Physiol Heart Circ Physiol. 2011 Mar;300(3):H1021-31. doi: 10.1152/ajpheart.00563.2009. Epub 2010 Dec 30.
Portal hypertension, a major complication of cirrhosis, is caused by both increased portal blood flow due to arterial vasodilation and augmented intrahepatic vascular resistance due to sinusoidal constriction. In this study, we examined the possible involvement of resident macrophages in the tone regulation of splanchnic blood vessels using bile duct ligated (BDL) portal hypertensive rats and an in vitro organ culture method. In BDL cirrhosis, the number of ED2-positive resident macrophages increased by two- to fourfold in the vascular walls of the mesenteric artery and extrahepatic portal vein compared with those in sham-operated rats. Many ED1-positive monocytes were also recruited into this area. The expression of inducible nitric oxide (NO) synthase (iNOS) mRNA was increased in the vascular tissues isolated from BDL rats, and accordingly, nitrate/nitrite production was increased. Immunohistochemistry revealed that iNOS was largely expressed in ED1-positive and ED2-positive cells. We further analyzed the effect of iNOS expression on vascular smooth muscle contraction using an in vitro organ culture system. iNOS mRNA expression and nitrate production significantly increased in vascular tissues (without endothelium) incubated with 1 μg/ml lipopolysaccharide (LPS) for 6 h. Immunohistochemistry indicated that iNOS was largely expressed in ED2-positive resident macrophages. α-Adrenergic-stimulated contractility of the mesenteric artery was greatly suppressed by LPS treatment and was restored by N(G)-nitro-L-arginine methyl ester (NO synthase inhibitor); in contrast, portal vein contractility was largely unaffected by LPS. Sodium nitroprusside (NO donor) and 8-bromo-cGMP showed greater contractile inhibition in the mesenteric artery than in the portal vein with decreasing myosin light chain phosphorylation. In the presence of an α-adrenergic agonist, the mesenteric artery cytosolic Ca(2+) level was greatly reduced by sodium nitroprusside; however, the portal vein Ca(2+) level was largely unaffected. These results suggest that the induction of iNOS in monocytes/macrophages contributes to a hypercirculatory state in the cirrhosis model rat in which the imbalance of the responsiveness of visceral vascular walls to NO (mesenteric artery >> portal vein) may account for the increased portal venous flow in portal hypertension.
门静脉高压症是肝硬化的一个主要并发症,是由动脉扩张引起的门静脉血流量增加和窦状隙收缩引起的肝内血管阻力增加所致。在这项研究中,我们使用胆管结扎(BDL)门静脉高压大鼠和体外器官培养方法,研究了固有巨噬细胞在内脏血管张力调节中的可能作用。在 BDL 肝硬化中,与假手术大鼠相比,肠系膜动脉和肝外门静脉血管壁中的 ED2 阳性固有巨噬细胞数量增加了 2 至 4 倍。许多 ED1 阳性单核细胞也被募集到这个区域。从 BDL 大鼠分离的血管组织中诱导型一氧化氮合酶(iNOS)mRNA 的表达增加,相应地,硝酸盐/亚硝酸盐的产生增加。免疫组织化学显示,iNOS 主要在 ED1 阳性和 ED2 阳性细胞中表达。我们进一步使用体外器官培养系统分析了 iNOS 表达对血管平滑肌收缩的影响。血管组织(无内皮)孵育 1μg/ml 脂多糖(LPS)6 小时后,iNOSmRNA 表达和硝酸盐生成显著增加。免疫组织化学显示,iNOS 主要在 ED2 阳性固有巨噬细胞中表达。LPS 处理大大抑制了肠系膜动脉的α-肾上腺素能刺激收缩,并被 N(G)-硝基-L-精氨酸甲酯(一氧化氮合酶抑制剂)恢复;相反,门静脉收缩对 LPS 影响不大。与门静脉相比,硝普钠(NO 供体)和 8-溴-cGMP 对肠系膜动脉的收缩抑制作用更大,同时降低肌球蛋白轻链磷酸化。在α-肾上腺素能激动剂存在的情况下,硝普钠使肠系膜动脉细胞浆 Ca(2+)水平大大降低;然而,门静脉 Ca(2+)水平基本不受影响。这些结果表明,单核细胞/巨噬细胞中 iNOS 的诱导导致肝硬化模型大鼠的高循环状态,其中内脏血管壁对 NO 的反应性失衡(肠系膜动脉>门静脉)可能导致门静脉高压时门静脉血流量增加。